Clinical Trial Update: Pan-Malaria Transmission-Blocking Vaccine AnAPN1 [Phase 1]

View source ↗

Summary

Phase 1 trial of the AnAPN1 pan-malaria transmission-blocking vaccine has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• AnAPN1 Pan-Malaria Transmission-Blocking Vaccine (AnAPN1)

Snippet

Sponsor: Centre de Recherche Médicale de Lambaréné | Conditions: Malaria | Phase 1 | Status: COMPLETED